Treatment of resistant atrial fibrillation: how far do we have to go?;Fibrillation auriculaire resistante: Jusqu'ou faut-il aller dans le tráitement?

Revue Medicale de Bruxelles

Volumn 20, Issue 4, 1999, Pages

  Verbeet, Th ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Non pharmacological treatment; Resistant atrial fibrillation

Indexed keywords

ANTIARRHYTHMIC AGENT;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CATHETER ABLATION; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART PACING; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RECURRENT DISEASE;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; PACEMAKER, ARTIFICIAL; RECURRENCE;

EID: 8844248730     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation : Current understandings and research imperatives. J Am Coll Cardiol 1993; 2: 1830-4
2. Benjamin E, Levy D, Vaziri S et al: Independent risk factors for atrial fibrillation in a population based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-4
3. Flaker G, Blackshear J, Mcbride R et al: Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 1992; 20: 527-32
4. Takahashi N, Seki A, Imataka K et al: Clinical features of paroxysmal atrial fibrillation: An observation of 94 patients. Jpn Heart J 1981; 22: 143-9
5. Echt D, Liebson P, Mitchell L et al: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781-8
6. Strangl K, Seitz K, Wirtzfeld A et al: Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. PACE 1990; 13: 2080-5
7. Sueda T, Nagata H, Orihashi K et al: Efficacy of a simple left atrial procedure for chronic atrial fibrillation in mitral valves operations. Ann thorac Surg 1997; 63: 1070-5
8. Bjerkelund C, Orning O: The efficacy of anticoagulant therapy in preventing embolism related to DC cardioversion of atrial fibrillation. Am J Cardiol 1969; 23: 208-15
9. Alt E, Ammer R, Lehmann G et al: Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. Am Heart J 1997; 134: 419-25
10. Wijffels M, Kirchof C, Dorland R et al: Atrial fibrillation begets atrial fibrillation: A study in awake, chronically instrumented goats. Circulation 1995; 92: 1954-68
11. Schmitt C, Alt E, Plewan A et al: Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol 1996; 28: 994-9
12. Verbeet T, Castro J, Morissens M et al: Le traitement des arythmies par cathétérisme: un réel espoir de guérison. Journal de Cardiologie 1996; 5: 136-46